This tracker examines Executive Actions taken by the Trump administration that have the potential to impact LGBTQ+ people’s health. It lists the action taken by date, provisions relevant to LGBTQ+ health, and describes potential impact, including litigation challenging these actions.

Political leaders on both sides point fingers at health insurers for high costs and patient frustrations. How much blame do insurers, in fact, deserve for our health system’s problems? In this three-part video series, KFF’s Larry Levitt considers this question and the complicated answer, exploring what’s driving rising insurance premiums, whether insurers provide value, and who we trust to decide what gets covered and at what price.

Costly health insurance premiums are straining employers and consumers alike. But, it’s underlying health care spending, especially for hospital care, that’s driving costs. KFF’s Larry Levitt looks at how hospital consolidation and employer demands for broad networks affect insurers’ ability, and willingness, to control prices in this first video of a three-part series on health insurers and rising health care costs.

Insurers take a cut of every premium dollar for overhead and profit. The question isn't just whether they profit, but also whether we’re getting value in return. KFF’s Larry Levitt breaks down how much goes to administrative costs and profit and how that varies across private insurance markets and Medicare, and considers what a Medicare-for-all system, which would be operated by the government, would address and what might be left unresolved in this second video of a three-part series on health insurers and rising health care costs.

Deciding what health care gets covered largely falls to health insurers, and it’s not a role that wins them many fans. A KFF poll finds prior authorization is the single biggest burden insured adults say they face beyond cost.

Detailed state and national data related to the 2025 Reconciliation Law Medicaid Work Requirements

The global health architecture includes a number of diverse international organizations with different mandates, governance models, financing structures, and operational approaches. This KFF resource looks across a range of variables to provide a descriptive mapping of 14 key global health and related international institutions. It is intended to inform discussions about synergies and coordination, duplication, comparative advantage, shared challenges, and architectural reform.

This tracker presents the most recent Medicaid monthly enrollment data.

At the close of every episode, Chip asks his guests the same question: ‘What keeps you up at night?’ In this highlights episode, we share intriguing responses on AI’s role in health care. From deepfakes and misinformation to bias and the risk of losing the human connection at the heart of care, these highlights capture some of the top issues today.

This tracker provides data on global COVID-19 cases and deaths by country, region, and income-level. Additionally, the tracker reports current closure, economic, and health system policy responses to the COVID-19 pandemic globally. This tracker will be updated as new data are available.

This publication describes KFF's survey methodology and data collection standards, including how the polling team reaches survey respondents, works to be representative, and partners with other news organizations on its polling projects.

This report examines how LGBTQ+ adults' experiences with health care costs and access compare to those of non-LGBTQ+ adults, finding that LGBTQ+ adults face significantly greater challenges affording and accessing care.

States are taking different regulatory approaches to AI mental health tools in response to concerns about chatbots providing inaccurate or potentially dangerous advice. Laws and pending legislation in some states restrict AI from providing or advertising itself as therapy, while others focus on data protections, disclosures, and patient consent requirements.

This data note presents key data points describing the current state of the Medicaid program as it affects women.

This State and Federal Reproductive Rights Litigation tracker aggregates information about ongoing litigation regarding abortion bans and restrictions, FDA approval of Mifepristone (an abortion pill) and other federal regulations.